|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.18 EUR | +0.90% |
|
-1.35% | -7.35% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.85% | -7.67% | -6.09% | +16.44% | +4.87% | +46.56% | +150.73% | +329.39% | +1,267.42% | 1T | |
| -0.67% | -5.56% | -2.86% | +12.36% | +21.72% | +47.28% | +49.02% | +45.31% | +103.38% | 613B | |
| +0.45% | -7.08% | -4.00% | +17.49% | +7.04% | +24.03% | +65.55% | +112.52% | +270.00% | 433B | |
| +1.18% | -2.23% | +8.41% | +13.65% | +9.60% | +41.06% | +35.71% | +1.61% | +46.40% | 350B | |
| +0.51% | -4.26% | -0.21% | +9.66% | +13.91% | +31.99% | +40.16% | +49.78% | +55.08% | 292B | |
| +1.87% | -9.72% | -17.15% | -12.36% | -15.29% | +4.90% | +7.08% | +41.26% | +126.70% | 239B | |
| +2.07% | -8.38% | -4.30% | +8.61% | -5.52% | -1.82% | -42.11% | +0.59% | +67.47% | 206B | |
| +1.19% | -3.20% | +3.84% | +17.50% | +16.26% | +26.03% | +56.41% | +66.67% | +120.37% | 204B | |
| +0.05% | -2.72% | +0.82% | -1.52% | +6.46% | +14.11% | +66.08% | +88.72% | +63.81% | 163B | |
| +0.42% | -1.41% | +4.95% | -5.34% | -0.02% | +5.80% | -28.91% | -44.91% | -29.17% | 143B | |
| -1.19% | +1.34% | +13.67% | +12.32% | +19.48% | +41.96% | +6.55% | -5.90% | -14.43% | 134B | |
| +2.94% | -1.89% | -9.15% | +11.93% | +6.13% | +1.88% | +41.31% | +141.06% | +379.80% | 119B | |
| 0.00% | -6.26% | -4.08% | +2.42% | +4.25% | +36.00% | +41.20% | +6.14% | -10.44% | 103B | |
| -0.26% | -6.42% | -0.31% | -4.54% | -10.20% | -9.41% | -20.91% | -12.09% | +2.10% | 103B | |
| -0.10% | -4.56% | -11.42% | -17.48% | -18.96% | -8.53% | +62.25% | +67.63% | +447.54% | 70.18B | |
| -2.26% | -7.97% | -4.19% | -0.45% | +9.33% | +25.29% | +21.69% | +46.02% | +11.66% | 55.08B | |
| +2.07% | +3.42% | -4.96% | +30.05% | +31.42% | +76.90% | -5.77% | -2.38% | -48.23% | 53.26B | |
| -2.00% | -1.12% | -2.66% | -1.63% | -11.03% | -13.55% | +25.38% | -7.67% | +226.04% | 51.77B | |
| -1.24% | -6.27% | -0.42% | +6.89% | -4.75% | +0.34% | +10.96% | - | - | 42.85B | |
| Average | +0.29% | -2.55% | -2.11% | +6.10% | +4.46% | +20.57% | +30.65% | +51.32% | +171.42% | 230.26B | |
| Weighted average by Cap. | +0.55% | -3.62% | -2.57% | +10.05% | +7.09% | +30.10% | +59.32% | +109.62% | +378.31% |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
